Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Promising cancer treatments were found, but the manufacturer closed.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Cepharanthine shows promise as a natural anticancer treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The combination treatment showed a higher response rate but no significant survival benefits.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.